Breaking News Instant updates and real-time market news.

BITCOIN

Bitcoin

, BTC

Bitcoin

12:30
12/01/17
12/01
12:30
12/01/17
12:30

The Intersection: Crypto and Wall Street This Week

As bitcoin, ethereum and other cryptocurrencies get increasing attention from investors, Wall Street and its traditional banks continue to adjust to the shift. Catch up on this week's top stories highlighting the intersection of these old guard and new school areas of finance with this recap compiled by The Fly: 1. BITCOIN HITS $11,000 BEFORE SLUMP: Bitcoin rose past $11,000 on Wednesday, gaining over $1,000 in less than 12 hours and hitting a record high for the cryptocurrency. However, the rapid increase raised concerns about a growing bubble and the digital currency fell quickly back below the $10,000 level it had just passed to recover near $9,500 during the day. 2. CFTC TO ALLOW BITCOIN PRODUCTS: On Friday, the U.S. Commodity Futures Trading Commission noted that the CME Group (CME) and the CBOE Futures Exchange (CBOE) self-certified new contracts for bitcoin futures products, and the Cantor Exchange self-certified a new contract for bitcoin binary options. CFTC chairman J. Christopher Giancarlo said, "Bitcoin, a virtual currency, is a commodity unlike any the Commission has dealt with in the past. As a result, we have had extensive discussions with the exchanges regarding the proposed contracts, and CME, CFE and Cantor have agreed to significant enhancements to protect customers and maintain orderly markets...Nevertheless, investors should be aware of the potentially high level of volatility and risk in trading these contracts." Once the contracts are launched, commission staff will engage in a variety of risk-monitoring activities and will continue to assess whether further changes are required to the contract design and settlement processes. 3. CME PLANS DEC. 18 LAUNCH: Concurrent with the CFTC announcement, CME Group announced that it has self-certified the initial listing of its Bitcoin futures contract to launch Monday, December 18, 2017. "We are pleased to bring Bitcoin futures to market after working closely with the CFTC and market participants to design a regulated offering that will provide investors with transparency, price discovery, and risk transfer capabilities," said chief executive officer Terry Duffy. "Though we have worked through a lengthy, comprehensive process with the CFTC to get to this point, we recognize bitcoin is a new, uncharted market that will continue to evolve, requiring continued collaboration with the commission and our clients going forward. At launch, our new Bitcoin futures contract will be subject to a variety of risk management tools, including an initial margin of 35%, position and intraday price limits, and a number of other risk and credit controls that CME Group offers on all of its products." CME Group's Bitcoin futures will be cash-settled, based on the CME CF Bitcoin Reference Rate which serves as a once-a-day reference rate of the U.S. dollar price of bitcoin. 4. NASDAQ TO LAUNCH FUTURES: Nasdaq (NDAQ) is planning to launch a bitcoin futures contract in 2018 making it the third U.S. exchange operator to plan derivatives contracts off the crytpocurrency, Reuters reported on Wednesday. Nasdaq, which does not yet have a date for the product, currently offers a bitcoin-based exchange-traded note on its Stockholm exchange. 5. STANDPOINT SETS $20,000 PRICE TARGET: On Wednesday, Standpoint Research analyst Ronnie Moas raised his 2018 price target for bitcoin to $20,000 from $14,000. There is "no way to justify" gold investments equaling 40 times than that of bitcoin, the analyst argues. He thinks an argument can be made that bitcoin will be equal to gold in 10-15 years. Currently, gold has $7T in investments to bitcoin's $180B, according to Moas. 6. "OUGHT TO BE OUTLAWED": On Bloomberg Television Wednesday, Nobel Prize-winning economist Joseph Stiglitz said, "Bitcoin is successful only because of its potential for circumvention, lack of oversight. So it seems to me it ought to be outlawed. It doesn't serve any socially useful function." He added, "It's a bubble that's going to give a lot of people a lot of exciting times as it rides up and then goes down." 7. OTHER BITCOIN PLAYS: Cryptocurrency revenues have been pointed to as reasons to be bullish on Advanced Micro Devices (AMD) and Nvidia (NVDA) in select research. PRICE ACTION: As of time of writing, bitcoin rose about 28% this week to $10,540 in U.S. dollars according to CoinDesk. Meanwhile, AMD shares fell 6% this week to $10.66 and Nvidia dropped nearly 10% on a weekly basis to $195.40. Bitcoin Investment Trust (GBTC) rose 25.7% this week to $1,620. WANT BITCOIN NEWS ALERTS?: To receive alerts on stories relating to bitcoin and other cryptocurrencies, Fly subscribers can enter "Bitcoin" into the "Add symbols" box of their portfolios.

BITCOIN

Bitcoin

BTC

Bitcoin

CME

CME Group

$149.54

1.71 (1.16%)

CBOE

CBOE Holdings

$123.43

2.5 (2.07%)

NDAQ

Nasdaq

$79.16

0.6 (0.76%)

NVDA

Nvidia

$200.71

4.29 (2.18%)

AMD

AMD

$10.89

0.06 (0.55%)

GBTC

Bitcoin Investment Trust

$1,521.00

-42 (-2.69%)

  • 05

    Dec

  • 09

    Jan

BITCOIN Bitcoin

11/20/17
STPT
11/20/17
NO CHANGE
STPT
Standpoint raises 2018 bitcoin price target to $14,000 from $11,000
Standpoint Research analyst Ronnie Moas raised his 2018 price target for bitcoin to $14,000 from $11,000. The price just crossed $8,180 and is now split-adjusted at $9,518 when you factor in the August fork spinoff bitcoin cash and the October fork spinoff bitcoin gold at $158, Moas writes in an email. The analyst sees the price of bitcoin hitting $60,000 five years. He says this is reached by 0.5% of the global total money invested currently in cash, stocks, bonds and gold going into the cryptocurrency.
11/27/17
11/27/17
DOWNGRADE
Target $30

Sell
BTIG says sell Square after 'overdone' bitcoin-fueled rally
As previously reported, BTIG analyst Mark Palmer downgraded Square (SQ) to Sell from Neutral, as he believes the stock's valuation reflects "emphatic and unimpeded growth" but fails to factor in the risks facing the company from increasing competition from First Data's (FDC) Clover, Vantiv (VNTV) and others. Other concerns, such as macroeconomic and credit-related risks, "did not go away when some investors suddenly viewed its shares as a play on a trendy cryptocurrency" following the company's confirmation that it is testing allowing users to buy and sell bitcoin using its app, Palmer tells investors. He has a $30 price target on Square shares, which closed Friday at $48.86.
11/03/17
STPT
11/03/17
NO CHANGE
STPT
Standpoint raises 2018 bitcoin target to $11,000 from $7,500
Standpoint analyst Ronnie Moas raised his 2018 price target for bitcoin to $11,000 from $7,500 while reiterating his belief that his 2027 target of $50,000 is conservative. Moas says the cryptocurrency market offers a "value play" unlike any he has seen in his 20 years in the business. "It remains undervalued by more than 75% even though bitcoin has jumped by 1200% already in the last year and it has doubled since Jamie Dimon referred to bitcoin as a scam just six weeks ago," the analyst writes in an email. Bitcoin Investment Trust (GBTC) closed yesterday up $3.00 to $930.00. To receive alerts on stories relating to bitcoin and other cryptocurrencies, Fly subscribers can enter the word "Bitcoin" into their portfolio.
11/29/17
STPT
11/29/17
NO CHANGE
STPT
Standpoint raises 2018 bitcoin price target to $20,000 from $14,000
Standpoint Research analyst Ronnie Moas raised his 2018 price target for bitcoin to $20,000 from $14,000. The current price is around $10,720 and the split-adjusted price is now $12,740 when factoring in Bitcoin Cash, Bitcoin Gold and Bitcoin Diamond, Moas tells investors in an intraday email. There is "no way to justify" gold investments equaling 40 times than that of bitcoin, the analyst argues. He thinks an argument can be made that bitcoin will be equal to gold in 10-15 years. Currently, gold has $7T in investments to bitcoin's $180B, according to Moas.
BTC Bitcoin

CME CME Group
$149.54

1.71 (1.16%)

07/12/17
SBSH
07/12/17
INITIATION
Target $140
SBSH
Buy
CME Group initiated with a Buy at Citi
Citi analyst Ben Herbert started CME Group with a Buy rating and $140 price target. "Deep" franchises in Energy, Fed Fund Futures and Treasury Futures and Options make CME the best positioned U.S. exchange, the analyst contends.
09/08/17
LEHM
09/08/17
INITIATION
Target $139
LEHM
Overweight
CME Group initiated with an Overweight at Barclays
Barclays analyst Jeremy Campbell started CME Group with an Overweight rating and $139 price target. The analyst initiated U.S. Brokers, Asset Managers & Exchanges with a Neutral industry view.
07/12/17
SBSH
07/12/17
DOWNGRADE
Target $16
SBSH
Sell
Virtu Financial downgraded to Sell from Neutral at Citi
Citi analyst Ben Herbert downgraded Virtu Financial (VIRT) to Sell and lowered his price target for the shares to $16 from $17 after taking over lead coverage from William Katz. The analyst has concerns over peak penetration, dividend pressure and the likely reduction of consensus estimates. He recommends a pair trade of long CME Group (CME), short Virtu.
08/16/17
DBAB
08/16/17
NO CHANGE
Target $135
DBAB
Buy
CME Group reiterated as top exchange pick at Deutsche Bank
Deutsche Bank analyst Brian Bedell reiterates CME Group as his top exchange pick after hosting investor meetings with management. The company's "multiple organic growth opportunities" make the stock much more than just a play on interest rates or macro volatility, Bedell tells investors in a research note. He keeps a Buy rating on CME with a $135 price target.
CBOE CBOE Holdings
$123.43

2.5 (2.07%)

10/05/17
WELS
10/05/17
NO CHANGE
Target $120
WELS
Outperform
CBOE Holdings price target raised to $120 from $106 at Wells Fargo
Wells Fargo raised its price target for CBOE Holdings to $120 from $106 on valuation. The analyst reiterates an Outperform rating on the shares.
10/16/17
RBCM
10/16/17
DOWNGRADE
Target $108
RBCM
Sector Perform
CBOE Holdings downgraded to Sector Perform at RBC Capital on limited upside
As previously noted, RBC Capital analyst Peter Lenardos downgraded CBOE Holdings to Sector Perform from Outperform but also raised his price target to $108 from $100. Lenardos says he remains impressed with sustained momentum in the company's high margin proprietary trading volume and anticipates a sector-wide multiple expansion, but the 45% year-to-date stock price appreciation captures its near-term upside.
10/16/17
RBCM
10/16/17
DOWNGRADE
RBCM
Sector Perform
CBOE Holdings downgraded to Sector Perform from Outperform at RBC Capital
09/08/17
LEHM
09/08/17
INITIATION
Target $105
LEHM
Equal Weight
CBOE Holdings initiated with an Equal Weight at Barclays
Barclays analyst Jeremy Campbell started CBOE Holdings with an Equal Weight rating and $105 price target. The analyst initiated U.S. Brokers, Asset Managers & Exchanges with a Neutral industry view.
NDAQ Nasdaq
$79.16

0.6 (0.76%)

10/09/17
BOFA
10/09/17
DOWNGRADE
BOFA
Underperform
Nasdaq downgraded to Underperform at BofA/Merrill
As previously reported, BofA/Merrill downgraded Nasdaq to Underperform from Neutral and trimmed its price target to $75 from $77. Analyst Michael Carrier believes shares should underperform the group due to lack of benefits from increased volatility, lack of capital management flexibility, some regulatory change, and strong competition in several segments.
10/09/17
BOFA
10/09/17
DOWNGRADE
BOFA
Underperform
Nasdaq downgraded to Underperform from Neutral at BofA/Merrill
09/08/17
LEHM
09/08/17
INITIATION
Target $85
LEHM
Overweight
Nasdaq initiated with an Overweight at Barclays
Barclays analyst Jeremy Campbell started Nasdaq with an Overweight rating and $85 price target. The analyst initiated U.S. Brokers, Asset Managers & Exchanges with a Neutral industry view.
07/27/17
UBSW
07/27/17
NO CHANGE
Target $85
UBSW
Buy
Nasdaq price target raised to $85 from $80 at UBS
UBS analyst Alex Kramm raised his price target on Nasdaq to $85 from $80 as the company posted a solid beat on both the top and bottom line. The analyst remains comfortable the company can achieve its growth targets over the long term despite lumpiness along the way. He also cited new initiatives that will eventually be supportive of its growth. Kramm reiterated his Buy rating on Nasdaq shares.
NVDA Nvidia
$200.71

4.29 (2.18%)

11/13/17
BMOC
11/13/17
UPGRADE
Target $200
BMOC
Market Perform
Nvidia upgraded to Market Perform at BMO Capital on strong data center business
As noted earlier, BMO Capital analyst Ambrish Srivastava upgraded Nvidia to Market Perform from Underperform and raised his price target to $200 from $135. Srivastava says the company has demonstrated a "far stronger" data center business than he had forecast and its leverage is greater than anticipated. The analyst adds that his prior negative view was based on anticipated deceleration in the gaming industry, however the business wins at Nintendo and help from the cryptocurrency market allowed Nvidia to achieve higher levels that expected.
11/13/17
BMOC
11/13/17
UPGRADE
BMOC
Market Perform
Nvidia upgraded to Market Perform from Underperform at BMO Capital
11/13/17
11/13/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. J.M. Smucker (SJM) upgraded to Positive from Neutral at Susquehanna with analyst Pablo Zuanic saying he believes the rout of food stocks is ebbing and since this company is the worst performing stock in his coverage universe, he chose to play the food trade with it. 2. Delek US (DK) upgraded to Strong Buy from Outperform at Raymond James with analyst Justin Jenkins saying it will benefit from a wider Brent-WTI spread. 3. Nvidia (NVDA) upgraded to Market Perform from Underperform at BMO Capital with analyst Ambrish Srivastava saying the company has demonstrated a "far stronger" data center business than he had forecast and its leverage is greater than anticipated. 4. Praxair (PX) upgraded to Buy from Hold at Argus with analyst Bill Selesky saying the company is well positioned to deliver stronger Earnings Per Share growth thanks to its mix of high-growth businesses driving above-industry-average margins, earnings, and returns on invested capital. 5. TD Ameritrade (AMTD) upgraded to Buy from Hold at Deutsche Bank with analyst Brian Bedell saying trading volumes are improving, trade pricing will hold up better than expected and the Scottrade integration is going very well. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/17/17
DAIW
11/17/17
UPGRADE
Target $260
DAIW
Buy
Nvidia upgraded to Buy from Outperform at Daiwa
Daiwa analyst Deepak Sitaraman upgraded Nvidia to Buy from Outperform and raised his price target on the shares to $260 from $140.
AMD AMD
$10.89

0.06 (0.55%)

11/10/17
JEFF
11/10/17
NO CHANGE
Target $19
JEFF
Buy
Jefferies says good intellectual property makes AMD undervalued
In a research note titled "What's Good IP Going For These Days?," Jefferies analyst Mark Lipacis says recent acquisitions of semiconductor companies with good intellectual property, such as ARM, Mobileye and Linear Technology, have garnered enterprise-to-sales multiples of five to 27 times. With an enterprise-to-sales ratio of two times, AMD looks undervalued, Lipacis contends. He believes the company has a "unique" combination of intellectual property in x86 and GPUs. The analyst keeps a Buy rating on AMD with a $19 price target. The chipmaker closed yesterday down 59c to $11.12.
11/08/17
STFL
11/08/17
NO CHANGE
STFL
Stifel says Intel purported hiring of AMD exec furthers competition with Nvidia
Commenting on reports that Raja Koduri, the head of AMD's (AMD) Radeon Technologies Group, is leaving the company and speculation that he would join Intel (INTC), Stifel analyst Kevin Cassidy said that, if true, this news points toward Intel working to build a stronger GPU and general purpose parallel processor to compete with Nvidia (NVDA). The analyst, who said "Intel is clearly not going to let Nvidia run away with the AI market," views Intel's developing strategy as positive for AMD too.
11/07/17
ADAM
11/07/17
NO CHANGE
Target $20
ADAM
Buy
AMD GPU deal with Intel adds upside optionality, says Canaccord
Canaccord analyst Matthew Ramsay noted AMD (AMD) announced a semi-custom deal with Intel (INTC) for the use of AMD's Vega GPU on Intel's multi-chip package for the notebook market. The analyst sees this as further solidifying the ability of AMD to monetize its intellectual property, which is consistent with his long-term thesis. Ramsay believes the risk/reward remains tilted to the upside and he reiterated his Buy rating and $20 price target on AMD shares.
11/29/17
GSCO
11/29/17
NO CHANGE
Target $10.4
GSCO
Sell
AMD losing share in multiple markets, says Goldman Sachs
Goldman analyst Toshiya Hari said Mercury's (MRCY) Q3 volume and pricing data indicates AMD (AMD) is losing shares. Hari lowered AMD 2019/20 earnings estimates by 11%/8%, respectively, due to disappointing market share performance across multiple markets. Hari views AMD's current risk/reward as negatively skewed and reiterates his Sell rating and lowered his price target to $10.40 from $11.40 on shares.
GBTC Bitcoin Investment Trust
$1,521.00

-42 (-2.69%)

TODAY'S FREE FLY STORIES

10:55
12/15/17
12/15
10:55
12/15/17
10:55
Conference/Events
Jefferies software/cybersecurity analyst holds analyst/industry conference call »

Analyst DiFucci, along…

CSCO

Cisco

$37.90

-0.25 (-0.66%)

, PANW

Palo Alto Networks

$147.38

1.95 (1.34%)

10:55
12/15/17
12/15
10:55
12/15/17
10:55
Conference/Events
Jefferies software/cybersecurity analyst holds analyst/industry conference call »

Analyst DiFucci, along…

CSCO

Cisco

$37.90

-0.25 (-0.66%)

PANW

Palo Alto Networks

$147.38

1.95 (1.34%)

SYMC

Symantec

$28.75

0.12 (0.42%)

CHKP

Check Point

$106.30

-0.13 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

  • 17

    Jan

  • 26

    Feb

ACHN

Achillion

10:51
12/15/17
12/15
10:51
12/15/17
10:51
Recommendations
Achillion analyst commentary  »

Achillion CMO departure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAGP

Plains GP Holdings

$21.29

0.11 (0.52%)

10:50
12/15/17
12/15
10:50
12/15/17
10:50
Options
Notable option play in Plains GP as a position adjusted »

Notable option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NMRK

Newmark

, BGCP

BGC Partners

$15.23

-0.56 (-3.55%)

10:46
12/15/17
12/15
10:46
12/15/17
10:46
Syndicate
Breaking Syndicate news story on Newmark, BGC Partners »

Newmark indicated to open…

NMRK

Newmark

BGCP

BGC Partners

$15.23

-0.56 (-3.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    May

  • 15

    Dec

FCX

Freeport McMoRan

$16.64

0.45 (2.78%)

10:45
12/15/17
12/15
10:45
12/15/17
10:45
Options
Freeport McMoRan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
12/15/17
12/15
10:45
12/15/17
10:45
General news
Chicago Fed's Evans voted against the rate hike »

Chicago Fed's Evans…

TEVA

Teva

$18.42

1.116 (6.45%)

10:44
12/15/17
12/15
10:44
12/15/17
10:44
Upgrade
Teva rating change  »

Credit Suisse takes Teva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$19.49

0.26 (1.35%)

, CS

Credit Suisse

$17.59

0.065 (0.37%)

10:44
12/15/17
12/15
10:44
12/15/17
10:44
Periodicals
U.S. judge dismisses $3B suit against Deutsche, Credit Suisse, Bloomberg says »

A U.S. judge has thrown…

DB

Deutsche Bank

$19.49

0.26 (1.35%)

CS

Credit Suisse

$17.59

0.065 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACHN

Achillion

10:40
12/15/17
12/15
10:40
12/15/17
10:40
Hot Stocks
Achillion reports resignation of Chief Medical Officer »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NMRK

Newmark

, BGCP

BGC Partners

$15.23

-0.56 (-3.55%)

10:39
12/15/17
12/15
10:39
12/15/17
10:39
Syndicate
Breaking Syndicate news story on Newmark, BGC Partners »

Newmark indicated to open…

NMRK

Newmark

BGCP

BGC Partners

$15.23

-0.56 (-3.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    May

  • 15

    Dec

TEVA

Teva

$18.39

1.08 (6.24%)

10:37
12/15/17
12/15
10:37
12/15/17
10:37
Upgrade
Teva rating change  »

Teva upgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CXRX

Concordia

$0.86

0.3261 (61.08%)

10:37
12/15/17
12/15
10:37
12/15/17
10:37
Hot Stocks
Concordia says 'unaware' of material change to account for market activity »

Concordia International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AU

AngloGold

$9.21

0.045 (0.49%)

10:35
12/15/17
12/15
10:35
12/15/17
10:35
Options
AngloGold put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKS

AK Steel

$5.26

-0.025 (-0.47%)

10:35
12/15/17
12/15
10:35
12/15/17
10:35
Hot Stocks
AK Steel says UAW members ratify labor agreement for Dearborn Works »

AK Steel announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NMRK

Newmark

, BGCP

BGC Partners

$15.23

-0.56 (-3.55%)

10:30
12/15/17
12/15
10:30
12/15/17
10:30
Syndicate
Breaking Syndicate news story on Newmark, BGC Partners »

Newmark indicated to open…

NMRK

Newmark

BGCP

BGC Partners

$15.23

-0.56 (-3.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    May

  • 15

    Dec

NDSN

Nordson

$143.86

16.95 (13.36%)

10:27
12/15/17
12/15
10:27
12/15/17
10:27
Recommendations
Nordson analyst commentary  »

Nordson price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NMRK

Newmark

, BGCP

BGC Partners

$15.23

-0.56 (-3.55%)

10:27
12/15/17
12/15
10:27
12/15/17
10:27
Syndicate
Breaking Syndicate news story on Newmark, BGC Partners »

Newmark indicated to open…

NMRK

Newmark

BGCP

BGC Partners

$15.23

-0.56 (-3.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    May

  • 15

    Dec

10:25
12/15/17
12/15
10:25
12/15/17
10:25
General news
Treasury Action: Treasuries will remain in a bear-bull tug-o-war into 2018 »

Treasury Action:…

10:25
12/15/17
12/15
10:25
12/15/17
10:25
Conference/Events
JPMorgan household/personal product analyst has analyst/industry conference call »

Beverages, Household…

FOX

21st Century Fox

$34.22

1.88 (5.81%)

, FOXA

21st Century Fox

$34.88

2.13 (6.50%)

10:25
12/15/17
12/15
10:25
12/15/17
10:25
Conference/Events
FBN Securities media analyst to hold an analyst/industry conference call »

Cable, Media &…

FOX

21st Century Fox

$34.22

1.88 (5.81%)

FOXA

21st Century Fox

$34.88

2.13 (6.50%)

DIS

Disney

$110.93

0.36 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

10:25
12/15/17
12/15
10:25
12/15/17
10:25
Conference/Events
JPMorgan insurance analyst has analyst/industry conference call »

Property & Casualty…

TEVA

Teva

$18.21

0.91 (5.26%)

10:24
12/15/17
12/15
10:24
12/15/17
10:24
Upgrade
Teva rating change  »

Teva upgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSAT

ViaSat

$72.72

0.46 (0.64%)

, EXC

Exelon

$40.80

-0.015 (-0.04%)

10:22
12/15/17
12/15
10:22
12/15/17
10:22
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

VSAT

ViaSat

$72.72

0.46 (0.64%)

EXC

Exelon

$40.80

-0.015 (-0.04%)

ORIG

Ocean Rig UDW

$24.55

-0.17 (-0.69%)

FTR

Frontier Communications

$8.69

-1.51 (-14.80%)

RIGL

Rigel Pharmaceuticals

$3.57

-0.15 (-4.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

ORCL

Oracle

$47.42

-2.77 (-5.52%)

, AMGN

Amgen

$174.92

-2.46 (-1.39%)

10:22
12/15/17
12/15
10:22
12/15/17
10:22
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

ORCL

Oracle

$47.42

-2.77 (-5.52%)

AMGN

Amgen

$174.92

-2.46 (-1.39%)

CRTO

Criteo

$24.42

-7.19 (-22.75%)

FIT

Fitbit

$6.20

-0.62 (-9.09%)

ELF

e.l.f. Beauty

$22.01

-0.121 (-0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

  • 18

    Jan

  • 03

    Feb

  • 25

    Mar

  • 30

    Apr

  • 17

    May

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.